105 related articles for article (PubMed ID: 7161194)
1. Conformations of protein moieties and chromophore-protein interactions in the antitumor antibiotics, macromomycin and auromomycin, characterized by IR and CD spectral analysis.
Miwa N
J Antibiot (Tokyo); 1982 Nov; 35(11):1553-60. PubMed ID: 7161194
[TBL] [Abstract][Full Text] [Related]
2. Studies on the reconstitution of macromomycin a d auromomycin from the chromophore and protein moieties.
Naoi N; Miwa T; Okazaki T; Watanabe K; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Jul; 35(7):806-13. PubMed ID: 7174534
[TBL] [Abstract][Full Text] [Related]
3. Evidence for involvement of a free radical in DNA-cleaving reaction by macromomycin and auromomycin.
Suzuki H; Kirino Y; Tanaka N
J Antibiot (Tokyo); 1983 May; 36(5):583-7. PubMed ID: 6874573
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of DNA-cleaving activities of macromomycin, auromomycin, and their free chromophores, and some DNA-binding characteristics.
Suzuki H; Tanaka N
J Antibiot (Tokyo); 1983 May; 36(5):575-82. PubMed ID: 6874572
[TBL] [Abstract][Full Text] [Related]
5. Role of pronase-resistant peptide segments of the antitumor protein antibiotics, auromomycin and macromomycin, in stabilizing cytocidal activity of the chromophore moieties to carcinoma cells.
Miwa N; Mizuno S; Okamoto S
J Antibiot (Tokyo); 1983 Jun; 36(6):721-7. PubMed ID: 6307961
[TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxicity to human lung normal diploid, virus-transformed and carcinoma cells by the antitumor antibiotics, auromomycin and macromomycin, and their non-protein chromophores.
Miwa N; Mizuno S; Okamoto S
J Antibiot (Tokyo); 1983 Jun; 36(6):715-20. PubMed ID: 6307960
[TBL] [Abstract][Full Text] [Related]
7. Conformation studies on and assessment by spectral analysis of the protein-chromophore interaction of the macromolecular antitumor antibiotic C-1027.
Otani T
J Antibiot (Tokyo); 1993 May; 46(5):791-802. PubMed ID: 8514634
[TBL] [Abstract][Full Text] [Related]
8. Characterization of secondary structure of neocarzinostatin apoprotein.
Saito K; Sato Y; Edo K; Akiyama-Murai Y; Koide Y; Ishida N; Mizugaki M
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3078-82. PubMed ID: 2534360
[TBL] [Abstract][Full Text] [Related]
9. An antitumor polypeptide antibiotic neocarzinostatin: the mode of apo-protein--chromophore interaction.
Edo K; Saito K; Akiyama-Murai Y; Mizugaki M; Koide Y; Ishida N
J Antibiot (Tokyo); 1988 Apr; 41(4):554-62. PubMed ID: 2967272
[TBL] [Abstract][Full Text] [Related]
10. Experimental pharmacology of auromomycin in L1210 tumor cells in vitro and in vivo.
Samy TS; Siegel PJ; Hopper WE; Krishan A
Cancer Res; 1984 Aug; 44(8):3202-7. PubMed ID: 6589039
[TBL] [Abstract][Full Text] [Related]
11. Contrasts in the actions of protein antibiotics on deoxyribonucleic acid structure and function.
Kappen LS; Goldberg IH; Samy TS
Biochemistry; 1979 Nov; 18(23):5123-7. PubMed ID: 159069
[TBL] [Abstract][Full Text] [Related]
12. Antitumor proteins of Streptomyces macromomyceticus: purification and characterization of auromomycin, macromomycin A, and macromomycin D.
Vandré DD; Montgomery R
Biochemistry; 1982 Jul; 21(14):3343-52. PubMed ID: 6810921
[TBL] [Abstract][Full Text] [Related]
13. DNA strand scission of methanol-extracted chromophores of macromomycin and auromomycin.
Naoi N; Kumada Y; Yamashita T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1982 Jul; 35(7):934-6. PubMed ID: 7174544
[No Abstract] [Full Text] [Related]
14. Requirement for reducing agents in deoxyribonucleic acid strand scisson by the purified chromophore of auromomycin.
Kappen LS; Napier MA; Goldberg IH; Samy TS
Biochemistry; 1980 Oct; 19(21):4780-5. PubMed ID: 7426628
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure analysis of auromomycin apoprotein (macromomycin) shows importance of protein side chains to chromophore binding selectivity.
Van Roey P; Beerman TA
Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6587-91. PubMed ID: 2771945
[TBL] [Abstract][Full Text] [Related]
16. Characterization of auromomycin-resistant hamster cell mutants that display a multidrug resistance phenotype.
Rauscher FJ; Beerman TA; Baker RM
Mol Pharmacol; 1990 Aug; 38(2):198-206. PubMed ID: 2143555
[TBL] [Abstract][Full Text] [Related]
17. Computer modeling analysis for enediyne chromophore-apoprotein complex of macromolecular antitumor antibiotic C-1027.
Okuno Y; Otsuka M; Sugiura Y
J Med Chem; 1994 Jul; 37(15):2266-73. PubMed ID: 8057275
[TBL] [Abstract][Full Text] [Related]
18. Strand scission of deoxyribonucleic acid by neocarzinostatin, auromomycin, and bleomycin: studies on base release and nucleotide sequence specificity.
Takeshita M; Kappen LS; Grollman AP; Eisenberg M; Goldberg IH
Biochemistry; 1981 Dec; 20(26):7599-606. PubMed ID: 6173064
[TBL] [Abstract][Full Text] [Related]
19. Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin.
Constantine KL; Colson KL; Wittekind M; Friedrichs MS; Zein N; Tuttle J; Langley DR; Leet JE; Schroeder DR; Lam KS
Biochemistry; 1994 Sep; 33(38):11438-52. PubMed ID: 7918358
[TBL] [Abstract][Full Text] [Related]
20. Structural study of crystalline auromomycin. Preliminary X-ray diffraction study of auromomycin and macromomycin.
Sieker LC; Samy TS
J Mol Biol; 1984 Apr; 174(4):739-42. PubMed ID: 6726802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
